http://www.genprex.com
Genprex, Inc. Company Intro
At Genprex, we are committed to pioneering a new approach to treating cancer, based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex™ immunogene therapy, or Oncoprex.
Industry
Healthcare
Genprex, Inc. Headquaters
Health Discovery Building
Austin,78712
United States
Genprex, Inc. Share price
14 Sep 2022 09:21 GMT
$1.7500
-0.01 (-0.57 %)
Genprex, Inc. Market cap
$81.992 M
WMC RANKING
2023
Genprex, Inc. # 327
BiotechnologyLatest Genprex, Inc. News
23 Mar 2023
News snapshot: Trillion Energy International, Therma Bright ...
Genprex Inc chairman, president and chief executive officer, Rodney Varner has commended the US Food and Drug Administration's (FDA) initiative that aims to...
23 Mar 2023
100+ Active Companies working to develop 100+ Pipeline ...
In January 2022, Genprex, Inc. announced that it has expanded its oncology research and development pipeline to include Small-cell Lung Cancer (SCLC) as an...
23 Mar 2023
News snapshot: Trillion Energy International, Therma Bright ...
Genprex Inc chairman, president and chief executive officer, Rodney Varner has commended the US Food and Drug Administration's (FDA) initiative that aims to...
WMC Market Score
WMC Market to Revenue Score
Genprex, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Genprex, Inc. | USD | $0 | $18,877 | $-18,866 | $820M | 327 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Genprex, Inc. Social Followers vs Top 4 Industry Competitors
Genprex, Inc. Post vs Top 4 Industry Competitors
Genprex, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Genprex, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Genprex, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Genprex, Inc. | 0 | 13.13 | 0.03 | 0 | 0 | 0 | 5.93 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
